Doxorubicin hydrochloride ≥95% (by TLC)
Supplier: Enzo Life Sciences
BML-GR319-0005
BML-GR319-0025
89158-906EA
176.96
CAD
89158-906
89158-908
Doxorubicin hydrochloride ≥95% (by TLC)
Doxorubicin hydrochloride
Topoisomerase inhibitor
A broad spectrum antitumor agent. Induces DNA damage by intercalating into DNA and inhibiting topoisomerase II. Binds covalently to DNA. Inhbibits reverse transcriptase, RNA polymerase and the catalytic activity of Dnmt1. Immunosuppressive. Antineoplastic. Induces apoptosis. Down regulates c-myc and c-jun in doxorubicin-sensitive cells.
Formula:
C₂₇H₂₉NO₁₁·HCl |
MDL Number:
MFCD00077757 CAS Number: 25316-40-9 |
|
Learn more

About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...